Myelodysplastic Syndromes
Showing 51 - 75 of 840
Acute Myeloid Leukemia, MDS, Chronic Myelomonocytic Leukemia Trial in Worldwide (JNJ-74856665, AZA, VEN)
Active, not recruiting
- Acute Myeloid Leukemia
- +2 more
- JNJ-74856665
- +2 more
-
Birmingham, Alabama
- +22 more
Jan 27, 2023
MDS, Anemia Trial in Germany (Luspatercept Injection)
Recruiting
- Myelodysplastic Syndromes
- Anemia
- Luspatercept Injection
-
Berlin, Germany
- +18 more
Jan 25, 2023
Acute Myeloid Leukemia, MDS Trial in United States (SL-172154)
Recruiting
- Acute Myeloid Leukemia
- Myelodysplastic Syndromes
-
Duarte, California
- +12 more
Jan 23, 2023
MDS Trial in Worldwide (MBG453, Placebo, Hypomethylating agents)
Active, not recruiting
- Myelodysplastic Syndromes
- MBG453
- +2 more
-
Duarte, California
- +46 more
Jan 20, 2023
Acute Myeloid Leukemia, Adult, MDS Trial in Marseille, Paris, Pierre-Bénite (ABD-3001)
Active, not recruiting
- Acute Myeloid Leukemia, Adult
- Myelodysplastic Syndromes
-
Marseille, France
- +2 more
Jan 19, 2023
Leukemia, Leukemia, Myeloid, Leukemia, Myeloid, Acute Trial in Worldwide (Decitabine, PDR001, MBG453)
Active, not recruiting
- Leukemia
- +7 more
- Decitabine
- +3 more
-
Boston, Massachusetts
- +10 more
Jan 19, 2023
Stem Cell Transplant Complications, Graft Vs Host Disease, Myeloid Leukemia, Acute Trial in Boston (radiation, drug, biological,
Recruiting
- Stem Cell Transplant Complications
- +4 more
- Radiation
- +7 more
-
Boston, MassachusettsDana Farber Cancer Institute
Jan 19, 2023
MDS Trial in Saint Louis (DEC-C, MyeloSeq-HD)
Recruiting
- Myelodysplastic Syndromes
- DEC-C
- MyeloSeq-HD
-
Saint Louis, MissouriWashington University School of Medicine
Jan 18, 2023
Colorectal Cancer, Hematologic Malignancy, Rectum Cancer Trial in Cleveland (Vactosertib, Fludarabine Phosphate,
Recruiting
- Colorectal Cancer
- +11 more
- Vactosertib
- +4 more
-
Cleveland, OhioUniversity Hospitals Cleveland Medical Center, Case Comprehensiv
Jan 18, 2023
Acute Myeloid Leukemia, MDS Trial in Ulm (drug, combination product, other)
Recruiting
- Acute Myeloid Leukemia
- Myelodysplastic Syndromes
- Venetoclax
- +4 more
-
Berlin, Germany
- +9 more
Jan 13, 2023
MDS, Chronic Myelomonocytic Leukemia, Acute Myeloid Leukemia Trial in Sydney (Decitabine/Cedazuridine 35 Mg-100 Mg ORAL TABLET,
Recruiting
- Myelodysplastic Syndromes
- +2 more
- Decitabine/Cedazuridine 35 Mg-100 Mg ORAL TABLET
- Defactinib
-
Sydney, New South Wales, Australia
- +3 more
Jan 12, 2023
MDS, Graft Vs Host Disease, Graft-versus-host-disease Trial in Miami (Busulfan, Melphalan, Fludarabine)
Not yet recruiting
- Myelodysplastic Syndromes
- +2 more
- Busulfan
- +3 more
-
Miami, FloridaMiami Cancer Institute
Jan 10, 2023
Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, Biphenotypic Acute Leukemia Trial in Tampa (Fludarabine, Melphalan, Total
Active, not recruiting
- Acute Myeloid Leukemia
- +17 more
- Fludarabine
- +2 more
-
Tampa, FloridaH. Lee Moffitt Cancer Center & Research Institute
Jan 10, 2023
Acute Myeloid Leukemia, MDS, Myeloproliferative Tumor Trial in Boston (CIML NK, Fludarabine, Cyclophosphamide)
Recruiting
- Acute Myeloid Leukemia
- +3 more
- CIML NK
- +2 more
-
Boston, Massachusetts
- +1 more
Jan 6, 2023
MDS, Myeloid Leukemia, Allogeneic Stem Cell Transplantation Trial in Pittsburgh (IFN-? (interferon gamma-1b) injection)
Recruiting
- Myelodysplastic Syndromes
- +2 more
- IFN-γ (interferon gamma-1b) injection
-
Pittsburgh, PennsylvaniaUPMC Hillman Cancer Center
Jan 5, 2023
MDS, Acute Myeloid Leukemia Trial in France (BST-236)
Recruiting
- Myelodysplastic Syndromes
- Acute Myeloid Leukemia
-
Amiens, France
- +16 more
Jan 2, 2023
Multiple Myeloma, Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia Trial in Charlottesville (Pre-biotic foods/drinks)
Completed
- Multiple Myeloma
- +11 more
- Pre-biotic foods/drinks
-
Charlottesville, VirginiaUniversity of Virginia
Jan 2, 2023
MDS Trial in Worldwide (Talacotuzumab, Daratumumab)
Completed
- Myelodysplastic Syndromes
-
Saint Louis, Missouri
- +20 more
Dec 28, 2022
Acute Lymphoblastic Leukemia, Acute Myelogenous Leukemia, MDS Trial in Tucson (Bendamustine, Cyclophosphamide)
Recruiting
- Acute Lymphoblastic Leukemia
- +12 more
-
Tucson, ArizonaThe University of Arizona Cancer Center
Dec 13, 2022
Acute Lymphoblastic Leukemia in Remission, Acute Myeloid Leukemia in Remission, MDS Trial in Houston (CliniMACS)
Not yet recruiting
- Acute Lymphoblastic Leukemia in Remission
- +10 more
- CliniMACS
-
Houston, Texas
- +1 more
Dec 8, 2022
MDS Trial in Worldwide (Magrolimab, Azacitidine, Placebo)
Active, not recruiting
- Myelodysplastic Syndromes
- Magrolimab
- +2 more
-
Birmingham, Alabama
- +168 more
Dec 7, 2022